Investigating enzymes that metabolize fatty acids and their role in diseases.
STUDIES ON FATTY ACID METABOLIZING CYTOCHROME P450 ENZYMES
This study is looking at certain enzymes in your body that help break down fats and other substances, to see how they affect things like blood pressure and diseases such as high blood pressure, brain injuries, and cancer, with the hope of finding new ways to treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11115751 on NIH RePORTER |
What this research studies
This research focuses on understanding the functions of specific cytochrome P450 enzymes, particularly the CYP4F family, which are crucial for metabolizing fatty acids and other compounds in the body. By examining how these enzymes influence processes like blood pressure regulation and their association with diseases such as hypertension, brain injury, and cancer, the research aims to identify potential drug targets. The approach includes detailed functional and structural studies of these enzymes to clarify their roles in health and disease, which could lead to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from hypertension, traumatic brain injury, or certain types of cancer.
Not a fit: Patients with conditions unrelated to fatty acid metabolism or the specific diseases being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies for conditions like hypertension and cancer.
How similar studies have performed: Previous research has shown promise in targeting cytochrome P450 enzymes for therapeutic purposes, indicating a potential for success in this area.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Brixius-Anderko, Simone — University of Pittsburgh at Pittsburgh
- Study coordinator: Brixius-Anderko, Simone
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.